These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4101278)

  • 1. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Dopa and Parkinsonism.
    Calne DB; Sandler M
    Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract]   [Full Text] [Related]  

  • 5. On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients.
    Pfeiffer R; Ebadi M
    J Neurochem; 1972 Sep; 19(9):2175-81. PubMed ID: 5072392
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopa-decarboxylase inhibitors.
    Lancet; 1973 May; 1(7810):979-80. PubMed ID: 4121597
    [No Abstract]   [Full Text] [Related]  

  • 7. L-Dopa and pyridoxine.
    Tran N
    Lancet; 1972 Jul; 2(7766):45-6. PubMed ID: 4113642
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
    Gey KF; Burkard WP
    Ann N Y Acad Sci; 1969 Sep; 166(1):213-24. PubMed ID: 5308031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
    Nurzia A
    Clin Ter; 1975 Feb; 72(3):289-95. PubMed ID: 1132216
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.
    Dietrichson P
    Acta Neurol Scand Suppl; 1972; 51():111-3. PubMed ID: 4514333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in the treatment of parkinsonism].
    Dowzenko A
    Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
    Gattringer B; Steinhäusl H
    Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
    Holmsen R; Kvan L; Presthus J; Thoresen GB
    Acta Neurol Scand Suppl; 1972; 51():121-2. PubMed ID: 4514336
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.
    Messiha FS; Hsu TH; Bianchine JR
    J Clin Invest; 1972 Feb; 51(2):452-5. PubMed ID: 5009125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Catecholamines" in the brain.
    Weiner WJ; Klawans HL
    N Engl J Med; 1970 Feb; 282(9):513-4. PubMed ID: 5411876
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H
    Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.